Similarly, several studies demonstrated that 6× and 8× R-CHOP are equally effective to manage patients with advanced-stage DLBCL, with the former resulting in less toxicity [12, 15, 18, 19, 52, 57]. Here, DDIT3 is linked to diffuse large B-cell lymphoma.